Skip to main content
Smart Investors Daily
SS

NASDAQ · SSKN

STRATA Skin Sciences, Inc.

Healthcare · Medical - Devices

$0.00

Up+$0.00 (+0.00%)

Updated Oct 24, 2026, 2:58 PM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
6.29M
P/E ratio
-6.13
Dividend yield
0.00%
52-week range
— – —
Volume
4.89K
Avg. volume
4.17M

Price performance · SSKN

SSKN price history

1M range · 0 trading sessions · Daily adjusted prices

SSKN does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SSKN news

The latest Smart Investors Daily articles mentioning SSKN.

SSKN research

Overview

Company profile and research snapshot.

Company profile

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
SSKN recent ratings
DateFirmRatingTarget
Feb 27, 2025Maxim GroupBuy—
May 16, 2023CG CapitalOutperform—
Nov 3, 2020HC Wainwright & Co.Buy—
Mar 17, 2020HC Wainwright & Co.Neutral—
Dec 9, 2019Ladenburg ThalmannBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

STRATA Skin Sciences to Present Illustrative Case Series on Excimer Laser Phototherapy at 2026 Fall Clinical Dermatology Conference

STRATA Skin Sciences, Inc. ("STRATA" or the "Company"), a global leader in excimer laser therapy dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced its presentation of seven illustrative cases on targeted 308-nm excimer laser phototherapy for localized and inflammatory autoimmune skin diseases at the 2026 Fall Clinical Dermatology Conference, taking place October 8-11, 2026 in Las Vegas.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.